139 related articles for article (PubMed ID: 27108524)
1. Establishment and adipocyte differentiation of polycystic ovary syndrome-derived induced pluripotent stem cells.
Yang S; Ding S; Jiang X; Sun B; Xu Q
Cell Prolif; 2016 Jun; 49(3):352-61. PubMed ID: 27108524
[TBL] [Abstract][Full Text] [Related]
2. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of polycystic ovary syndrome-derived human embryonic stem cells into adipocytes and their glucose consumption.
Li J; Wang F; Kong HJ; Liu WW; Sun YP
Gynecol Endocrinol; 2012 Nov; 28(11):871-3. PubMed ID: 22571227
[TBL] [Abstract][Full Text] [Related]
4. Differential genes in adipocytes induced from polycystic and non-polycystic ovary syndrome-derived human embryonic stem cells.
Wang F; Liu WW; Chen XM; Kong HJ; Li J; Sun YP
Syst Biol Reprod Med; 2014 Jun; 60(3):136-42. PubMed ID: 24517280
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming.
Leung KL; Sanchita S; Pham CT; Davis BA; Okhovat M; Ding X; Dumesic P; Grogan TR; Williams KJ; Morselli M; Ma F; Carbone L; Li X; Pellegrini M; Dumesic DA; Chazenbalk GD
Clin Epigenetics; 2020 Nov; 12(1):181. PubMed ID: 33228780
[TBL] [Abstract][Full Text] [Related]
6. Hyperactive CREB signaling pathway involved in the pathogenesis of polycystic ovarian syndrome revealed by patient-specific induced pluripotent stem cell modeling.
Huang CC; Chen MJ; Lan CW; Wu CE; Huang MC; Kuo HC; Ho HN
Fertil Steril; 2019 Sep; 112(3):594-607.e12. PubMed ID: 31277818
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of primordial germ cells from premature ovarian insufficiency-derived induced pluripotent stem cells.
Yang S; Ding S; He S; He L; Gao K; Peng S; Shuai C
Stem Cell Res Ther; 2019 May; 10(1):156. PubMed ID: 31151408
[TBL] [Abstract][Full Text] [Related]
8. Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.
Fisch SC; Nikou AF; Wright EA; Phan JD; Leung KL; Grogan TR; Abbott DH; Chazenbalk GD; Dumesic DA
Fertil Steril; 2018 Dec; 110(7):1367-1376. PubMed ID: 30503136
[TBL] [Abstract][Full Text] [Related]
9. Generation of Induced Pluripotent Stem Cells from Human Epidermal Keratinocytes.
Yang YH; Zhang RZ; Cheng S; Xu B; Tian T; Shi HX; Xiao L; Chen RH
Cell Reprogram; 2018 Dec; 20(6):356-364. PubMed ID: 30388030
[TBL] [Abstract][Full Text] [Related]
10. Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS).
Khatun M; Lundin K; Naillat F; Loog L; Saarela U; Tuuri T; Salumets A; Piltonen TT; Tapanainen JS
Stem Cell Rev Rep; 2024 Jan; 20(1):67-87. PubMed ID: 37768523
[TBL] [Abstract][Full Text] [Related]
11. Characterization of embryonic stem cell model of polycystic ovary syndrome.
Zhang Y; Zhang YS; Xue FX
In Vitro Cell Dev Biol Anim; 2016 May; 52(5):507-11. PubMed ID: 27112161
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
13. Establishment of polycystic ovary syndrome-derived human embryonic stem cell lines.
Li PF; Wang F; Kong HJ; Zhao F; Bai AH; Chen XM; Sun YP
Gynecol Endocrinol; 2012 Jan; 28(1):25-8. PubMed ID: 21780950
[TBL] [Abstract][Full Text] [Related]
14. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells.
Boraas LC; Guidry JB; Pineda ET; Ahsan T
PLoS One; 2016; 11(1):e0145084. PubMed ID: 26771179
[TBL] [Abstract][Full Text] [Related]
16. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
17. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
18. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
Montgomery A; Wong A; Gabers N; Willerth SM
Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
[TBL] [Abstract][Full Text] [Related]
19. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
